Lensiprazine
SLV314 (Lensiprazine) is a dual-action small molecule functioning as a dopamine D2 receptor antagonist and serotonin reuptake inhibitor (SRI) . It is utilized in preclinical research to investigate neuropsychiatric conditions such as schizophrenia and bipolar disorder, including in vitro receptor binding assays and in vivo behavioral models.
Product Specifications
CAS Number
327026-93-7
Product Name Alternative
DopamineReceptor, Dopamine Receptor, D2, 5HTReceptor, 5HT Receptor, Lensiprazine, SLV 314, SLV314, SLV-314, serotonin reuptake
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
97.86% (May vary between batches)
Solubility
DMSO:50 mg/mL (118.34 mM)
Smiles
C[C@H]1OC2=C (C=CC=C2NC1=O) N3CCN (CCCC=4C=5C (NC4) =CC=C (F) C5) CC3
Molecular Formula
C24H27FN4O2
Molecular Weight
422.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IHUMANFRC6HISLY10UG 10 µg
Human MANF Recombinant Protein C-6His Tag Lyophilized 10ug
Sign In for Pricing
View Details